ETHYL 3-((2-((4-(N-(2-ETHYLBUTOXYCARBONYL)CARBAMIMIDOYL)ANILINO)METHYL)-1-METHYLBENZIMIDAZOLE-5-CARBONYL)-PYRIDIN-2-YLAMINO)PROPANOATE
UNII KY4HXQ4YME
Substance Identification & Data
This profile provides standardized clinical and technical data for Ethyl 3-((2-((4-(n-(2-ethylbutoxycarbonyl)carbamimidoyl)anilino)methyl)-1-methylbenzimidazole-5-carbonyl)-pyridin-2-ylamino)propanoate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) KY4HXQ4YME.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1610758-20-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C34H41N7O5 FLKVNYQKJOGRLQ-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Ethyl 3-((2-((4-(n-(2-ethylbutoxycarbonyl)carbamimidoyl)anilino)methyl)-1-methylbenzimidazole-5-carbonyl)-pyridin-2-ylamino)propanoate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.